A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial (RADIANT-3) of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: Updated Safety an...

by Strosberg, Jonathan R.
Published 2012

Multimodality approach for locally advanced esophageal cancer

by Almhanna, Khaldoun, Strosberg, Jonathan R
Published 2012

Intermittent bowel obstruction due to a retained wireless capsule endoscope in a patient with a small bowel carcinoid tumour

by Strosberg, Jonathan R, Shibata, David, Kvols, Larry K
Published 2007

The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types

by Hendifar, Andrew E., Dhall, Deepti, Strosberg, Jonathan R.
Published in Oncologist (2018)

Biology and Treatment of Metastatic Gastrointestinal Neuroendocrine Tumors

by Strosberg, Jonathan R., Nasir, Aejaz, Hodul, Pamela, Kvols, Larry
Published 2008

Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease

by Barnebee, Daniel, Morse, Brian, Strosberg, Jonathan R., Pejic, Marijan, Jeong, Daniel
Published in Case Rep Cardiol (2019)

Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review

by Broder, Michael S, Beenhouwer, David, Strosberg, Jonathan R, Neary, Maureen P, Cherepanov, Dasha
Published in World J Gastroenterol (2015)

Diagnostic performance of endoscopic ultrasound-guided fine-needle aspiration for cystic and non-cystic pancreatic neuroendocrine tumors

by Dhaliwal, Amaninder Jeet Singh, Strosberg, Jonathan R., Centeno, Barbara A., Vignesh, Shivakumar
Published in Endosc Int Open (2019)

A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms

by Al-Toubah, Taymeyah, Schell, Michael J., Cives, Mauro, Zhou, Jun-Min, Soares, Heloisa P., Strosberg, Jonathan R.
Published in Neuroendocrinology (2019)

The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas

by Strosberg, Jonathan R., Coppola, Domenico, Klimstra, David S., Phan, Alexandria T., Kulke, Matthew H., Wiseman, Gregory A., Kvols, Larry K.
Published 2010

First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas

by Strosberg, Jonathan R., Fine, Robert L., Choi, Junsung, Nasir, Aejaz, Coppola, Domenico, Chen, Dung-Tsa, Helm, James, Kvols, Larry
Published in Cancer (2010)

Peptide Receptor Radionuclide Therapy with Lu-177 Octreotate in patients with Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years Assessment

by Delpassand, Ebrahim S., Hamiditabar, Mohammadali, Ali, Muzammil, Roys, Joseph, Wolin, Edward M., O’Dorisio, Thomas M., Ranganathan, David, Strosberg, Jonathan R.
Published in Clin Nucl Med (2017)

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Revi...

by Strosberg, Jonathan R., Benson, Al B., Huynh, Lynn, Duh, Mei Sheng, Goldman, Jamie, Sahai, Vaibhav, Rademaker, Alfred W., Kulke, Matthew H.
Published 2014

EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors

by SALLER, JAMES, SEYDAFKAN, SHABNAM, SHAHID, MOHAMMAD, GADARA, MANOJ, CIVES, MAURO, ESCHRICH, STEVEN A., BOULWARE, DAVID, STROSBERG, JONATHAN R., AEJAZ, NASIR, COPPOLA, DOMENICO
Published in Cancer Genomics Proteomics (2019)

Incidence of Atrioventricular Block After Valve Replacement in Carcinoid Heart Disease

by Sunjic, Igor, Shin, Doosup, Sunjic, Katlynd M., Popat, Jesal V., Tran, Thanh, Chae, Sanders H., Caldeira, Christiano C., Strosberg, Jonathan R., Sayad, Dany
Published in Cardiol Res (2020)

A Phase II Study of RO4929097 in Metastatic Colorectal Cancer

by Strosberg, Jonathan R., Yeatman, Timothy, Weber, Jill, Coppola, Domenico, Schell, Michael J., Han, Gang, Almhanna, Khaldoun, Kim, Richard, Valone, Tiffany, Jump, Helen, Sullivan, Dan
Published in Eur J Cancer (2012)

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

by Yao, James C, Chan, Jennifer A, Mita, Alain C, Kundu, Madan G, Hermosillo Reséndiz, Karina, Hu, Ke, Ravichandran, Shoba, Strosberg, Jonathan R, Wolin, Edward M
Published in Onco Targets Ther (2017)

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

by Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
Published in Endocr Relat Cancer (2015)

Clinical outcomes of patients with gastrointestinal malignancies participating in phase I clinical trials

by Denson, Aaron, Burke, Nancy, Wapinsky, Georgine, Bertels, Barbara, Juan, Tzu-Hua, Lee, Jae, Springett, Gregory M., Strosberg, Jonathan R., Kim, Richard D., Sullivan, Dan M., Mahipal, Amit
Published in Am J Clin Oncol (2018)

Metastatic type 1 gastric carcinoid: A real threat or just a myth?

by Grozinsky-Glasberg, Simona, Thomas, Dimitrios, Strosberg, Jonathan R, Pape, Ulrich-Frank, Felder, Stephan, Tsolakis, Apostolos V, Alexandraki, Krystallenia I, Fraenkel, Merav, Saiegh, Leonard, Reissman, Petachia, Kaltsas, Gregory, Gross, David J
Published 2013